Ajax-Loading

Astellas Pharma Inc. - Long Term Debt

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Long-Term-Debt" stands at 564.89 Billion Japanese Yens as of 03/31/2025.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 26.17 percent compared to the value the year prior.
The 1 year change in percent is 26.17.
The 10 year change in percent is 78,795.67.

The Serie's long term average value is 122.20 Billion Japanese Yens. It's latest available value, on 03/31/2025, is 362.26 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2014, to it's latest available value, on 03/31/2025, is +784,473.61%.
The Serie's change in percent from it's maximum value, on 09/30/2024, to it's latest available value, on 03/31/2025, is -8.92%.

Long Term Debt for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Long Term Debt905,699,262,464.00
LogoJohnson & Johnson - Long Term Debt486,508,953,600.00
LogoAbbVie Inc - Long Term Debt399,570,305,024.00
LogoRoche Holding AG - Long Term Debt317,433,206,677.55
LogoAstraZeneca PLC - Long Term Debt280,205,508,085.11